drugset / Trial / NCT02097147

Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo

NCT02097147

Phase 1 Completed 202 enrolled Forest Laboratories
RandomizedParallel-groupTriple-blind

Summary

To compare the effects of vilazodone, paroxetine and placebo on sexual function in sexually active healthy adults.

Timeline

Start
2014-03
Primary completion
2014-09
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Paroxetine Small molecule 20 mg Oral
Subject Vilazodone Small molecule 20 mg Oral
Subject Vilazodone Small molecule 40 mg Oral

Indications

No indication recorded.